Detalhe da pesquisa
1.
Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician.
J Am Pharm Assoc (2003)
; 63(1): 284-294.e1, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36567216
2.
Readiness of community pharmacies to implement an opioid safety intervention.
J Am Pharm Assoc (2003)
; 63(1): 275-283.e1, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36496310
3.
Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies.
Subst Abus
; 43(1): 901-905, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35213293
4.
Pharmacogenomics in the clinic: genetic polymorphism contributing to venlafaxine-associated heart failure.
Pharmacogenomics
; 20(17): 1175-1178, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31799914